Skip to content

Category: Alzheimer'sSyndicate content

Study sheds light on evolution of human complexity

November 3, 2009

A painstaking analysis of thousands of genes and the proteins they encode shows that human beings are biologically complex, at least in part, because of the way humans evolved to cope with redundancie

A nervous system drug-by-design

October 26, 2009

Working like an architect, Prof.

Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk

October 25, 2009

SAN FRANCISCO -- Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Opht

AFFiRiS AG: Encouraging Results from Phase I Studies of Two Alzheimer's Candidate Vaccines Trigger EUR 10 Mio. Milestone Payment

October 20, 2009

Vienna, 20. October 2009: AFFiRiS AG today announced that the primary endpoints have been met for the Phase I clinical studies of its two Alzheimer's vaccines AD01 and AD02, which demonstrated favourable safety and tolerability profiles. These results trigger a 10 million EUR milestone payment from licensee GlaxoSmithKline Biologicals.

Smart rat 'Hobbie-J' produced by over-expressing a gene that helps brain cells communicate

October 19, 2009

AUGUSTA, Ga. -- Over-expressing a gene that lets brain cells communicate just a fraction of a second longer makes a smarter rat, report researchers from the Medical College of Georgia and East China Normal University.

APP -- Good, bad or both?

October 18, 2009

CHICAGO -- New data about amyloid precursor protein, or APP, a protein implicated in development of Alzheimer's disease, suggests it also may have a positive role -- directly affecting learning and memory during brain development. So is APP good or bad? Researchers at Georgetown University Medical Center say both, and that a balance of APP is critical.

Yerkes researchers present at 39th Annual Society for Neuroscience Conference

October 16, 2009

Neuroscience researchers from the Yerkes National Primate Research Center, Emory University, will present a wide range of research topics at the Society for Neuroscience's 39th annual meeting in Chicago, Oct. 17-21, 2009. The information below is a representation of the neuroscience research Yerkes scientists will be discussing.

New findings about brain proteins suggest possible way to fight Alzheimer's

October 6, 2009

DALLAS -- Oct. 6, 2009 -- The action of a small protein that is a major villain in Alzheimer's disease can be counterbalanced with another brain protein, researchers at UT Southwestern Medical Center have found in an animal study.

First direct information about the prion's molecular structure reported

October 5, 2009

A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions. In addition, the study has revealed surprisingly large structural differences between natural prions and the closest synthetic analogs that scientists have created in the lab.

Half-million low-income elderly affected by sweeping cuts to state safety net

October 1, 2009

An 81-year-old San Francisco woman with dementia, little money and an equally aged caregiver sister who is suffering from cancer.

A 72-year-old Riverside woman with Alzheimer's who cannot be left safely on her own, forcing her son to cut back his working hours to care for her.

Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimer's

October 1, 2009

TORONTO, Ont., October 1, 2009 -- People taking one of several drugs commonly prescribed to treat Alzheimer's disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications.

Protein inhibitor helps rid brain of toxic tau protein

September 29, 2009

Tampa, FL (September 30, 2009) -- Inhibiting the protein Hsp70 rapidly reduces brain levels of tau, a protein associated with Alzheimer's disease when it builds up abnormally inside nerve cells affecting memory, neuroscientists at the University of South Florida found. The study is reported online today in the Journal of Neuroscience.

Extra virgin olive oil compound may help prevent, treat Alzheimer's

September 29, 2009

PHILADELPHIA (September 29, 2009) -- Oleocanthal, a naturally-occurring compound found in extra-virgin olive oil, alters the structure of neurotoxic proteins believed to contribute to the debilitating effects of Alzheimer's disease. This structural change impedes the proteins' ability to damage brain nerve cells.

Sleep loss linked to increase in Alzheimer's plaques

September 24, 2009

Chronic sleep deprivation in a mouse model of Alzheimer's disease makes Alzheimer's brain plaques appear earlier and more often, researchers at Washington University School of Medicine in St. Louis report online this week in Science Express.

They also found that orexin, a protein that helps regulate the sleep cycle, appears to be directly involved in the increase.

University Hospitals Case Medical Center to test gammaglobulin treatment for Alzheimer's disease

September 24, 2009

Researchers from the Memory and Cognition Center at University Hospitals Case Medical Center will begin testing an intriguing new approach to slowing down the progression of Alzheimer's Disease (AD) using Intravenous Immune Globulin (IGIV), also known as gammaglobulin.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.